Showing results (71-80 of 101) with videos related to
Sort By:
Pageof 11
The Lancet Regional Health. Europe|November 7, 2025
Changing clinical perspectives on sex and healthcare disparities in ischaemic heart diseaseAngela Maas, Edina Cenko, Viola Vaccarino, et al.Journal of Hypertension|October 17, 2017
Perspectives on hypertension's prevalence, treatment and control in a high cardiovascular risk East European country: data from the SEPHAR III surveyMaria Dorobantu, Oana-Florentina Tautu, Doina Dimulescu, et al.Circulation. Cardiovascular Interventions|January 12, 2021
Sex Differences in Ischemic and Bleeding Outcomes in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From the TAO TrialJean-Guillaume Dillinger, Gregory Ducrocq, Yedid Elbez, et al.The American Journal of Cardiology|January 19, 2016
Comparison of Early Versus Delayed Oral β Blockers in Acute Coronary Syndromes and Effect on OutcomesRaffaele Bugiardini, Edina Cenko, Beatrice Ricci, et al.Journal of Human Hypertension|November 26, 2020
The Global Ambulatory Blood Pressure Monitoring (ABPM) in Heart Failure with Preserved Ejection Fraction (HFpEF) Registry. Rationale, design and objectivesMiguel Camafort-Babkowski, Akintunde Adeseye, Antonio Coca, et al.Cardiovascular Research|September 16, 2021
Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)Edina Cenko, Lina Badimon, Raffaele Bugiardini, et al.European Journal of Heart Failure|December 29, 2019
Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failurePiotr Ponikowski, Bridget-Anne Kirwan, Stefan D Anker, et al.European Heart Journal|November 17, 2019
Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysisPeter R Sinnaeve, Gregory G Schwartz, Daniel M Wojdyla, et al.Cardiovascular Research|April 14, 2020
Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and ThrombosisYvonne Alexander, Elena Osto, Arno Schmidt-Trucksäss, et al.The New England Journal of Medicine|May 24, 2008
Facilitated PCI in patients with ST-elevation myocardial infarctionStephen G Ellis, Michal Tendera, Mark A de Belder, et al.Pageof 11